Protocol Design Services & Products
-
Harbor Clinical FSP Model: Functional, Flexible, Fractional
11/17/2022
Take a look at a redefined FSP service model that adds enhanced flexibility in timing, scope, and level of resources assigned.
-
Cell & Gene Therapy
9/21/2021
Cell & Gene Therapy from WCG will help your teams navigate this ever-changing regulatory space and set your trials up for success.
-
Biometrics
4/28/2021
Advancing a novel therapy through clinical development is complicated. Not all therapies make it to the patients that need them.
-
Speed to Study
10/28/2019
Accelerate your drug to proof of concept with PCI’s Speed to Study™ services.
-
Adaptive Trial Design and Implementation
10/31/2018
Cytel brings its expertise in adaptive designs to the design and implementation of the industry’s most innovative clinical trials. These highly flexible trials raise peculiar challenges for enrollment, data collection and regulatory submission. Why not have the industry leaders in adaptive design working on your adaptive trials?
-
Data-Focused Clinical Research Services
10/31/2018
Cytel’s dedicated team of professionals is here to help you address an array of challenges when conducting drug development. Whether you face a complex statistical issue or the need for knowledgeable collaborators to handle biometrics and trial implementation, Cytel has skilled professionals available when you need them.
-
Data Science
10/31/2018
Cytel data scientists apply advanced statistical techniques including predictive modeling of biological processes and drug interactions to unlock the potential of big data. Our team supports biomarker discovery and diagnostic test development based on biomedical signals and images, and real world evidence analysis.
-
Hematology And Oncology
10/31/2018
Gain a competitive advantage for your study in the ever-evolving landscape of hematology and oncology drug and biologic clinical development.
-
Quantitative Pharmacology and Pharmacometrics
10/31/2018
Exposure (and Dose) Response Analyses, including pharmacokinetic and pharmacodynamics analyses, guide critical decisions in drug development. Cytel’s expert Quantitative Pharmacology and Pharmacometrics group delivers high quality solutions to help our customers get those decisions right.
-
CDISC Services
10/31/2018
Cytel has a strong track record in providing CDISC solutions and we are a CDISC Registered Solutions Provider. We have converted more than 150 studies as part of NDA submissions, all of which have been accepted by the FDA. The Clinical Data Interchange Standards Consortium (CDISC) devised the SDTM and ADaM models to standardize data structures for submission of raw and analysis data from clinical trials. These standard formats are increasingly expected by regulatory authorities including the FDA.